AtriCure (NASDAQ:ATRC) Raised to “Hold” at StockNews.com

StockNews.com upgraded shares of AtriCure (NASDAQ:ATRC – Free Report) from a sell rating to a hold rating in a research report report published on Thursday morning. Several other equities analysts also recently commented on the company. JPMorgan Chase & Co. cut their price objective on AtriCure from $60.00 to $50.00 and set an overweight rating […]

Leave a Reply

Your email address will not be published.

Previous post Mike Preston: Ravens, exposed as work-in-progress in loss to Browns, can’t be trusted yet | COMMENTARY
Next post Greenhill & Co., Inc. (NYSE:GHL) Now Covered by Analysts at StockNews.com